Pancreatic Cancer Chemoprevention Translational Workshop: Meeting Report

Mark Steven Miller, Peter Allen, Teresa A. Brentnall, Michael S Goggins, Ralph H Hruban, Gloria M. Petersen, Chinthalapally V. Rao, David C. Whitcomb, Randall E. Brand, Suresh T. Chari, Alison Klein, David M. Lubman, Andrew D. Rhim, Diane M. Simeone, Brian M. Wolpin, Asad Umar, Sudhir Srivastava, Vernon E. Steele, Jo Ann S Rinaudo

Research output: Contribution to journalArticle

Abstract

Pancreatic cancer is the fourth leading cause of cancer related deaths in the United States with a 5-year survival rate of less than 10%. The Division of Cancer Prevention of the National Cancer Institute sponsored the Pancreatic Cancer Chemoprevention Translational Workshop on September 10 to 11, 2015. The goal of the workshop was to obtain information regarding the current state of the science and future scientific areas that should be prioritized for pancreatic cancer prevention research, including early detection and intervention for high-risk precancerous lesions. The workshop addressed the molecular/genetic landscape of pancreatic cancer and precursor lesions, high-risk populations and criteria to identify a high-risk population for potential chemoprevention trials, identification of chemopreventative/immunopreventative agents, and use of potential biomarkers and imaging for assessing short-term efficacy of a preventative agent. The field of chemoprevention for pancreatic cancer is emerging, and this workshop was organized to begin to address these important issues and promote multi-institutional efforts in this area. The meeting participants recommended the development of an National Cancer Institute working group to coordinate efforts, provide a framework, and identify opportunities for chemoprevention of pancreatic cancer.

Original languageEnglish (US)
Pages (from-to)1080-1091
Number of pages12
JournalPancreas
Volume45
Issue number8
DOIs
StatePublished - Sep 1 2016

Fingerprint

Chemoprevention
Pancreatic Neoplasms
Education
National Cancer Institute (U.S.)
Population
Molecular Biology
Neoplasms
Survival Rate
Biomarkers
Research

Keywords

  • biomarkers
  • chemoprevention
  • clinical trials
  • early detection
  • high-risk patient cohorts
  • pancreatic cancer

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Endocrinology

Cite this

Miller, M. S., Allen, P., Brentnall, T. A., Goggins, M. S., Hruban, R. H., Petersen, G. M., ... Rinaudo, J. A. S. (2016). Pancreatic Cancer Chemoprevention Translational Workshop: Meeting Report. Pancreas, 45(8), 1080-1091. https://doi.org/10.1097/MPA.0000000000000705

Pancreatic Cancer Chemoprevention Translational Workshop : Meeting Report. / Miller, Mark Steven; Allen, Peter; Brentnall, Teresa A.; Goggins, Michael S; Hruban, Ralph H; Petersen, Gloria M.; Rao, Chinthalapally V.; Whitcomb, David C.; Brand, Randall E.; Chari, Suresh T.; Klein, Alison; Lubman, David M.; Rhim, Andrew D.; Simeone, Diane M.; Wolpin, Brian M.; Umar, Asad; Srivastava, Sudhir; Steele, Vernon E.; Rinaudo, Jo Ann S.

In: Pancreas, Vol. 45, No. 8, 01.09.2016, p. 1080-1091.

Research output: Contribution to journalArticle

Miller, MS, Allen, P, Brentnall, TA, Goggins, MS, Hruban, RH, Petersen, GM, Rao, CV, Whitcomb, DC, Brand, RE, Chari, ST, Klein, A, Lubman, DM, Rhim, AD, Simeone, DM, Wolpin, BM, Umar, A, Srivastava, S, Steele, VE & Rinaudo, JAS 2016, 'Pancreatic Cancer Chemoprevention Translational Workshop: Meeting Report', Pancreas, vol. 45, no. 8, pp. 1080-1091. https://doi.org/10.1097/MPA.0000000000000705
Miller, Mark Steven ; Allen, Peter ; Brentnall, Teresa A. ; Goggins, Michael S ; Hruban, Ralph H ; Petersen, Gloria M. ; Rao, Chinthalapally V. ; Whitcomb, David C. ; Brand, Randall E. ; Chari, Suresh T. ; Klein, Alison ; Lubman, David M. ; Rhim, Andrew D. ; Simeone, Diane M. ; Wolpin, Brian M. ; Umar, Asad ; Srivastava, Sudhir ; Steele, Vernon E. ; Rinaudo, Jo Ann S. / Pancreatic Cancer Chemoprevention Translational Workshop : Meeting Report. In: Pancreas. 2016 ; Vol. 45, No. 8. pp. 1080-1091.
@article{3f111a93f38243e1ba2712ddc7ec68dd,
title = "Pancreatic Cancer Chemoprevention Translational Workshop: Meeting Report",
abstract = "Pancreatic cancer is the fourth leading cause of cancer related deaths in the United States with a 5-year survival rate of less than 10{\%}. The Division of Cancer Prevention of the National Cancer Institute sponsored the Pancreatic Cancer Chemoprevention Translational Workshop on September 10 to 11, 2015. The goal of the workshop was to obtain information regarding the current state of the science and future scientific areas that should be prioritized for pancreatic cancer prevention research, including early detection and intervention for high-risk precancerous lesions. The workshop addressed the molecular/genetic landscape of pancreatic cancer and precursor lesions, high-risk populations and criteria to identify a high-risk population for potential chemoprevention trials, identification of chemopreventative/immunopreventative agents, and use of potential biomarkers and imaging for assessing short-term efficacy of a preventative agent. The field of chemoprevention for pancreatic cancer is emerging, and this workshop was organized to begin to address these important issues and promote multi-institutional efforts in this area. The meeting participants recommended the development of an National Cancer Institute working group to coordinate efforts, provide a framework, and identify opportunities for chemoprevention of pancreatic cancer.",
keywords = "biomarkers, chemoprevention, clinical trials, early detection, high-risk patient cohorts, pancreatic cancer",
author = "Miller, {Mark Steven} and Peter Allen and Brentnall, {Teresa A.} and Goggins, {Michael S} and Hruban, {Ralph H} and Petersen, {Gloria M.} and Rao, {Chinthalapally V.} and Whitcomb, {David C.} and Brand, {Randall E.} and Chari, {Suresh T.} and Alison Klein and Lubman, {David M.} and Rhim, {Andrew D.} and Simeone, {Diane M.} and Wolpin, {Brian M.} and Asad Umar and Sudhir Srivastava and Steele, {Vernon E.} and Rinaudo, {Jo Ann S}",
year = "2016",
month = "9",
day = "1",
doi = "10.1097/MPA.0000000000000705",
language = "English (US)",
volume = "45",
pages = "1080--1091",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Pancreatic Cancer Chemoprevention Translational Workshop

T2 - Meeting Report

AU - Miller, Mark Steven

AU - Allen, Peter

AU - Brentnall, Teresa A.

AU - Goggins, Michael S

AU - Hruban, Ralph H

AU - Petersen, Gloria M.

AU - Rao, Chinthalapally V.

AU - Whitcomb, David C.

AU - Brand, Randall E.

AU - Chari, Suresh T.

AU - Klein, Alison

AU - Lubman, David M.

AU - Rhim, Andrew D.

AU - Simeone, Diane M.

AU - Wolpin, Brian M.

AU - Umar, Asad

AU - Srivastava, Sudhir

AU - Steele, Vernon E.

AU - Rinaudo, Jo Ann S

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Pancreatic cancer is the fourth leading cause of cancer related deaths in the United States with a 5-year survival rate of less than 10%. The Division of Cancer Prevention of the National Cancer Institute sponsored the Pancreatic Cancer Chemoprevention Translational Workshop on September 10 to 11, 2015. The goal of the workshop was to obtain information regarding the current state of the science and future scientific areas that should be prioritized for pancreatic cancer prevention research, including early detection and intervention for high-risk precancerous lesions. The workshop addressed the molecular/genetic landscape of pancreatic cancer and precursor lesions, high-risk populations and criteria to identify a high-risk population for potential chemoprevention trials, identification of chemopreventative/immunopreventative agents, and use of potential biomarkers and imaging for assessing short-term efficacy of a preventative agent. The field of chemoprevention for pancreatic cancer is emerging, and this workshop was organized to begin to address these important issues and promote multi-institutional efforts in this area. The meeting participants recommended the development of an National Cancer Institute working group to coordinate efforts, provide a framework, and identify opportunities for chemoprevention of pancreatic cancer.

AB - Pancreatic cancer is the fourth leading cause of cancer related deaths in the United States with a 5-year survival rate of less than 10%. The Division of Cancer Prevention of the National Cancer Institute sponsored the Pancreatic Cancer Chemoprevention Translational Workshop on September 10 to 11, 2015. The goal of the workshop was to obtain information regarding the current state of the science and future scientific areas that should be prioritized for pancreatic cancer prevention research, including early detection and intervention for high-risk precancerous lesions. The workshop addressed the molecular/genetic landscape of pancreatic cancer and precursor lesions, high-risk populations and criteria to identify a high-risk population for potential chemoprevention trials, identification of chemopreventative/immunopreventative agents, and use of potential biomarkers and imaging for assessing short-term efficacy of a preventative agent. The field of chemoprevention for pancreatic cancer is emerging, and this workshop was organized to begin to address these important issues and promote multi-institutional efforts in this area. The meeting participants recommended the development of an National Cancer Institute working group to coordinate efforts, provide a framework, and identify opportunities for chemoprevention of pancreatic cancer.

KW - biomarkers

KW - chemoprevention

KW - clinical trials

KW - early detection

KW - high-risk patient cohorts

KW - pancreatic cancer

UR - http://www.scopus.com/inward/record.url?scp=84983427350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983427350&partnerID=8YFLogxK

U2 - 10.1097/MPA.0000000000000705

DO - 10.1097/MPA.0000000000000705

M3 - Article

C2 - 27518363

AN - SCOPUS:84983427350

VL - 45

SP - 1080

EP - 1091

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 8

ER -